126 related articles for article (PubMed ID: 18544620)
1. Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood.
Recabarren SE; Sir-Petermann T; Rios R; Maliqueo M; Echiburú B; Smith R; Rojas-García P; Recabarren M; Rey RA
J Clin Endocrinol Metab; 2008 Sep; 93(9):3318-24. PubMed ID: 18544620
[TBL] [Abstract][Full Text] [Related]
2. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Codner E; Maliqueo M; Echiburú B; Hitschfeld C; Crisosto N; Pérez-Bravo F; Recabarren SE; Cassorla F
J Clin Endocrinol Metab; 2006 Aug; 91(8):3105-9. PubMed ID: 16720659
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profile in sons of women with polycystic ovary syndrome.
Recabarren SE; Smith R; Rios R; Maliqueo M; Echiburú B; Codner E; Cassorla F; Rojas P; Sir-Petermann T
J Clin Endocrinol Metab; 2008 May; 93(5):1820-6. PubMed ID: 18230657
[TBL] [Abstract][Full Text] [Related]
4. Gonadal function in low birth weight infants: a pilot study.
Sir-Petermann T; Hitchsfeld C; Codner E; Maliqueo M; Iñiguez G; Echiburú B; Sánchez F; Crisosto N; Cassorla F
J Pediatr Endocrinol Metab; 2007 Mar; 20(3):405-14. PubMed ID: 17451079
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.
Crisosto N; Codner E; Maliqueo M; Echiburú B; Sánchez F; Cassorla F; Sir-Petermann T
J Clin Endocrinol Metab; 2007 Jul; 92(7):2739-43. PubMed ID: 17488788
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
Wachs DS; Coffler MS; Malcom PJ; Chang RJ
J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
[TBL] [Abstract][Full Text] [Related]
8. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
[TBL] [Abstract][Full Text] [Related]
9. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
10. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
[TBL] [Abstract][Full Text] [Related]
11. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
[TBL] [Abstract][Full Text] [Related]
12. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
13. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Maliqueo M; Codner E; Echiburú B; Crisosto N; Pérez V; Pérez-Bravo F; Cassorla F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4637-42. PubMed ID: 17848407
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ovarian function in 35-40-year-old women with polycystic ovary syndrome.
de Guevara AL; Crisosto N; Echiburú B; Preisler J; Vantman N; Bollmann J; Pérez-Bravo F; Sir-Petermann T
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):165-70. PubMed ID: 23845170
[TBL] [Abstract][Full Text] [Related]
15. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
Tosi F; Negri C; Perrone F; Dorizzi R; Castello R; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2012 May; 97(5):1712-9. PubMed ID: 22419715
[TBL] [Abstract][Full Text] [Related]
16. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
Moran LJ; Noakes M; Clifton PM; Norman RJ
J Clin Endocrinol Metab; 2007 Oct; 92(10):3796-802. PubMed ID: 17652213
[TBL] [Abstract][Full Text] [Related]
17. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.
Rey RA; Grinspon RP; Gottlieb S; Pasqualini T; Knoblovits P; Aszpis S; Pacenza N; Stewart Usher J; Bergadá I; Campo SM
Andrology; 2013 Jan; 1(1):3-16. PubMed ID: 23258624
[TBL] [Abstract][Full Text] [Related]
18. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
Das M; Gillott DJ; Saridogan E; Djahanbakhch O
Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
20. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
